• Payers Break New Ground Pharm Exec interviews in a Q&A format key experts on the evolving global landscape of market access and how payers are responding to the growing fiscal pressures on drug budgets and reimbursement. Impact of the US health reform bill on strategies for building access and obtaining a strong “value for investment” proposition from the payer community will be addressed in detail.

• THE CME FUNCTION: ADAPTING TO A GLOBAL STAKEHOLDER ENVIRONMENT
Pharm Exec sits down to talk with Gilead Executive Vice President for Commercial Operations Kevin Young on the company's effort to expand its development portfolio while meeting patient expectations for leadership in next generation HIV therapies.

• THE UPDATE ON OUTSOURCING
Knowledge Process Outsourcing: Pharma’s shifting stakeholder landscape ( physicians are no longer the primary influencers in many segments) includes having to reallocate promotional spend. As a result, many companies have begun outsourcing commercial analytics—the belief being that sales operations, marketing research and information technology can be more cost effectively done by third party specialists. But is this the best way to go?

• TBD
In preparation for "science's greatest night," the 2010 Prix Galien awards on September 28, former HHS Assistant Secretary for Health Dr. Eve Slater and Tufts Center for the Study of Drug Development Executive Director Ken Kaitin document the internal management changes needed to strengthen innovation in new drug discovery.

• SPECIAL SECTION PRODUCT MANAGER'S HANDBOOK - ARE YOU READY FOR GLOBAL E-CTD?
E-CDT is not just limited to the transfer of information. It also applies to the creation, review, life cycle management and archiving of electronic submissions, which is requiring companies to build and acquire new methodologies. Pharm Exec surveys the landscape on this emerging technological imperative.

Bonus Distribution:
PharmaForce Conference